At a time when UnitedHealth Group is grappling with public scrutiny, operational disruptions, and a federal investigation, the company’s board is proposing an unusually generous pay package—worth up to $60 million—for its CEO. The catch? He’s already served as CEO before.
The executive in question is Andrew Witty, the former CEO who returned in 2021 to steer the ship again. His new incentive-loaded package is set to be voted on by shareholders at UnitedHealth’s annual meeting this June. Critics say it’s the wrong message at the wrong time.
Witty’s return wasn’t exactly under normal circumstances. After briefly stepping away, he rejoined amid rising challenges for the $500 billion healthcare giant. UnitedHealth has faced mounting pressure over data breaches, antitrust scrutiny, and its role in consolidating power across insurance and medical services.
Now, the company’s board wants to reward Witty with a fresh equity-heavy plan that could balloon to $60 million—depending on company performance. That number has raised eyebrows among analysts and corporate governance experts alike.
“This kind of windfall for a ‘boomerang CEO’ is rare,” said one compensation consultant. “Especially when the company is under fire from regulators and the public.”
The package details: performance-linked—but aggressive
According to UnitedHealth’s latest proxy filing, Witty’s proposed pay includes stock options, performance shares, and restricted stock units. To unlock the full amount, the company would need to hit ambitious targets around revenue growth and share price gains.
Still, many investors are questioning the optics. The package comes on the heels of a data breach at subsidiary Change Healthcare, which disrupted operations across hospitals and providers. The company is also under investigation for potential anticompetitive behavior due to its vast vertical integration.
Some critics argue that instead of offering a mega-payout, UnitedHealth should be prioritizing internal reforms and patient trust.
“Witty already earns a base salary north of $1.5 million, with total comp previously hitting $20 million,” one shareholder group stated. “There’s no justification for layering on more unless it directly solves the company’s current problems.”
A high-stakes vote looms
Shareholders are set to cast their votes in June, and early signals suggest the outcome may be close. Proxy advisors like ISS and Glass Lewis have yet to weigh in, but their recommendations could swing institutional support.
For Witty and UnitedHealth’s board, it’s a defining moment—not just on executive pay, but on the broader question of corporate accountability. Can a multibillion-dollar healthcare empire justify this kind of reward while facing public backlash and legal scrutiny?
Witty hasn’t publicly commented on the pay package, but insiders say he remains focused on crisis management and restoring confidence among healthcare partners.
In a year when executive compensation is drawing fresh political and public attention, UnitedHealth’s vote is shaping up to be one of the most watched—and possibly most controversial—of 2025.
